REVERSE AGING: FROM SCIENCE FICTION TO SCIENCE, FROM MYTH TO VC REALITY
Life expectancy has jumped from 35 years (1800) to 82 today (+134%); can we expect to live 150 healthy years or more by the end of this...
top of page
From Lab to BIO champions
Passionate about Venture Capital and the Future of Life Sciences?
This blog is for you!
Topics dealing with early sciences, funding, entrepreneurs, Big Pharmas, M&A, patients care will be openly debate. There will be an important footprint on Therapeutics but Med Tech, Diagnostic and the revolution of Digital Health will also feed the posts. Discussion and feed back are always welcome thus do not hesitate to comment or email me.
BLOG: Bienvenue
Search
MITRAL VALVE: IS THERE ROOM FOR LATE VCs ENTRANTS?
February 23th 2021 With more than 50 products into development, including 10 in clinical phase, Mitral Regurgitation (MR) market...
THERAPEUTICS: HOW VCs HAVE ORCHESTRATED THE FANTASTIC COME BACK IN NEUROSCIENCES
February 1st 2021 Generics and late-stage clinical failures have led major Big Pharma to leave CNS practice. Prozac™, Zoloft™, Paxil™ in...
Edouard Caram
RNA THERAPIES: PUSHING THE FRONTIER OF DRUGGABILITY AND TREATMENTS
When Ram Aiyar former CEO of Corvidia (sold for 2,1 B USD to Novo Nordisk in June 20) decided last November 2020 to lead Korro Bio...
Edouard Caram
ORPHAN DRUGS: THE DILEMNA OF “NICHEBUSTERS”
December 1st 2020 Today, Noema Pharma rose 59 MMUSD in Series A to develop four products spun out from Roche to treat rare neurological...
Edouard Caram
Billion dollars exit is the new black !
November 27th 2020 Looking to 2019 six exceptional VC funded Therapeutics companies have been acquired for more than one billion. This...
BLOG: Blog2
BLOG: S'abonner
CONTACT
Many thanks for your interest in VClife. Should you need to contact me please mail me to:
BLOG: Contact
bottom of page